Integrative Cancer Therapies

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hann, D. M.
Right arrow Articles by Kaw, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hann, D. M.
Right arrow Articles by Kaw, O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Integrative Cancer Therapies, Vol. 4, No. 4, 294-300 (2005)
DOI: 10.1177/1534735405282109

Use of Complementary Therapies Among Breast and Prostate Cancer Patients During Treatment: A Multisite Study

D. M. Hann, PhD

American Cancer Society Behavioral Research Center, Atlanta, Georgia, dhann_1{at}yahoo.com

F. Baker, PhD

American Cancer Society Behavioral Research Center, Atlanta, Georgia

C. S. Roberts, PhD, MSW

University of South Florida School of Social Work, Tampa

C. Witt, LISW

University Hospitals of Cleveland, Cleveland, Ohio

J. McDonald, MSW, OSW-C

Presbyterian Hospital, Albuquerque, New Mexico

M. Livingston, LCSW, OSW-C

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

J. Ruiterman, LCSW

University of Southern California Norris Cancer Hospital, Los Angeles

R. Ampela, LCSW, BCD, OSW-C

North Shore University Hospital, Manhasset, New York

C. Crammer, MM, Mdiv

American Cancer Society Behavioral Research Center, Atlanta, Georgia

O. Kaw, MS

American Cancer Society Behavioral Research Center, Atlanta, Georgia

Purpose: The purpose of this study was to compare the use of complementary therapies (CT) among breast and prostate cancer patients during active cancer treatment. The authors compared use and beliefs about the role of CT in cancer recovery. Methods: A self-report survey was completed by 126 breast cancer patients and 82 prostate cancer patients as part of a multisite research project. The self-report questionnaire inquired about the use of various CTs, sources of information about CT, reasons for using CT, beliefs about the benefits and risks of CT, demographic characteristics, and cancer treatment history. Results: Most of the respondents were older than 50 years, Caucasian, married, had attended or completed college, and were less than 1 year postdiagnosis. Prostate cancer patients were significantly older than the breast cancer patients (P < .001). Several differences emerged between the groups. Compared to the prostate cancer patients, significantly more of the breast cancer patients reported using CT because they wanted to reduce the risk of recurrence (P < .01), play a more active role in recovery (P < .01), help manage stress (P < .01), take a more holistic approach (P < .01), or boost the immune system (P < .01). More of the prostate cancer patients reported using CT to have more control of their recovery (P < .05). The 2 groups also differed significantly (P < .01) on several beliefs about the potential benefits and risks of using CT.Conclusions: Most of the patients in this study had used some form of CT since the time of their diagnosis. Differences among breast and prostate cancer patients with regard to their use of CT during cancer treatment should be considered by oncology professionals who are discussing this topic with their patients.

Key Words: complementary therapy • quality of life • breast cancer • prostate cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Integr Cancer TherHome page
V. S. Eschiti
Lesson From Comparison of CAM Use by Women With Female-Specific Cancers to Others: It's Time to Focus on Interaction Risks With CAM Therapies
Integr Cancer Ther, December 1, 2007; 6(4): 313 - 344.
[Abstract] [PDF]


Home page
J Oncol PractHome page
A. M. Gross, Q. Liu, and S. Bauer-Wu
Prevalence and Predictors of Complementary Therapy Use in Advanced-Stage Breast Cancer Patients
J. Oncol. Pract, November 1, 2007; 3(6): 292 - 295.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
D. Hann, S. Allen, D. Ciambrone, and A. Shah
Use of complementary therapies during chemotherapy: influence of patients' satisfaction with treatment decision making and the treating oncologist.
Integr Cancer Ther, September 1, 2006; 5(3): 224 - 231.
[Abstract] [PDF]